HKSE - Delayed Quote HKD

JD Health International Inc. (6618.HK)

39.350
-1.100
(-2.72%)
At close: 4:08:23 PM GMT+8
Loading Chart for 6618.HK
  • Previous Close 40.450
  • Open 39.600
  • Bid 39.350 x --
  • Ask 39.500 x --
  • Day's Range 39.150 - 40.300
  • 52 Week Range 19.480 - 41.000
  • Volume 9,728,154
  • Avg. Volume 19,034,720
  • Market Cap (intraday) 125.907B
  • Beta (5Y Monthly) 1.09
  • PE Ratio (TTM) 27.52
  • EPS (TTM) 1.430
  • Earnings Date Aug 13, 2025 - Aug 18, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 42.24

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

ir.jdhealth.com

3,564

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6618.HK

View More

Performance Overview: 6618.HK

Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

6618.HK
39.29%
HANG SENG INDEX (^HSI)
16.31%

1-Year Return

6618.HK
29.87%
HANG SENG INDEX (^HSI)
19.33%

3-Year Return

6618.HK
14.83%
HANG SENG INDEX (^HSI)
15.96%

5-Year Return

6618.HK
58.36%
HANG SENG INDEX (^HSI)
4.33%

Compare To: 6618.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6618.HK

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    129.43B

  • Enterprise Value

    74.23B

  • Trailing P/E

    28.30

  • Forward P/E

    28.01

  • PEG Ratio (5yr expected)

    5.57

  • Price/Sales (ttm)

    2.03

  • Price/Book (mrq)

    2.16

  • Enterprise Value/Revenue

    1.18

  • Enterprise Value/EBITDA

    13.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.16%

  • Return on Assets (ttm)

    1.07%

  • Return on Equity (ttm)

    7.95%

  • Revenue (ttm)

    58.16B

  • Net Income Avi to Common (ttm)

    4.16B

  • Diluted EPS (ttm)

    1.430

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    51.24B

  • Total Debt/Equity (mrq)

    0.47%

  • Levered Free Cash Flow (ttm)

    2.35B

Research Analysis: 6618.HK

View More

Company Insights: 6618.HK

Research Reports: 6618.HK

View More

People Also Watch